市場調查報告書
商品編碼
1468526
2024-2032 年透析市場報告(按類型(血液透析、腹膜透析)、產品和服務(服務、設備、消耗品、透析藥物)、最終用戶(中心透析、家庭透析)和地區)Dialysis Market Report by Type (Hemodialysis, Peritoneal Dialysis), Product and Services (Services, Equipment, Consumables, Dialysis Drugs), End User (In-center Dialysis, Home Dialysis), and Region 2024-2032 |
2023年,IMARC Group透析市場規模達1,158億美元。透析治療報銷政策的不斷增加、需要術後透析的腎臟移植患者數量的增加以及對腎臟疾病早期診斷和干涉的日益關注是推動市場的一些因素。
對於腎臟無法自然發揮功能的人來說,透析是一種重要的腎臟替代療法。這種醫療程序在消除患者血液中的毒素、多餘的水、鹽和溶質方面發揮著至關重要的作用,有效地恢復了更健康的平衡。透析的主要目的是淨化血液並恢復體內適當的電解質水平。此療法有兩種主要形式:血液透析和腹膜透析。血液透析涉及血液的外部淨化,這是一個發生在體外的過程。這項技術可以有效淨化血液中的雜質,幫助患者恢復穩定。另一方面,腹膜透析依靠腹膜(腹部內壁)來淨化血液。透過利用腹膜作為透析介質,該方法提供了一種內部血液淨化方法。血液透析和腹膜透析都有助於治療各種與腎臟相關的疾病。這些治療通常用於解決急性腎損傷、治療慢性腎臟疾病、支持腎臟移植手術,或在移植不可行時作為永久解決方案。透析的重要性怎麼強調都不為過,因為它可以顯著提高患有腎功能障礙的人的生活品質。透過精心實施和醫療技術的不斷進步,透析繼續成為需要腎臟支持的患者的生命線。
全球市場的主要驅動力是慢性腎臟病盛行率的不斷上升。與此一致的是,容易出現腎臟相關問題的老化人口不斷增加,對市場做出了重大貢獻。此外,人們對腎臟健康和可用治療方案的認知不斷增強,正在對市場產生積極影響。除此之外,科技的快速進步帶來了更有效率的透析程序,為市場提供了許多機會。此外,創新透析技術研發的大量投資正在刺激市場。此外,糖尿病(腎臟疾病的主要原因)的發生率較高,也推動了對透析的需求。此外,發展中地區醫療基礎設施的擴張也推動了市場的發展。對居家透析解決方案不斷成長的需求正在增強市場。
生活方式的改變導致腎臟併發症
生活方式改變的不斷升級趨勢正在刺激市場。現代生活方式以不良飲食習慣、久坐和高壓力為特徵,導致腎臟併發症增加。富含加工食品、高鹽含量和水分不足的不健康飲食可能導致高血壓和糖尿病等慢性疾病,這是腎臟疾病的主要原因。生活方式因素與腎臟併發症之間的相關性促使慢性腎臟疾病的盛行率上升。腎臟相關問題的增加隨後增加了對透析治療的需求,因為受影響的個體需要腎臟替代療法來維持他們的生活品質。不斷擴大的患者群體需要擴大透析服務,進一步推動透析市場的成長。因此,醫療保健提供者、醫療設備製造商和研究人員有動力開發創新的解決方案和策略來滿足這一不斷成長的需求並提供有效的透析干預措施。
擴大私人透析診所和中心
私人透析診所和中心的擴張正在提振市場。這些私人設施具有幾個關鍵優勢,有助於擴大市場。私人診所通常根據個別患者的獨特需求提供專門和個人化的護理。這種程度的客製化提高了患者滿意度和治療效果,吸引了更多的客戶並刺激了市場需求。此外,私人透析中心往往提供更靈活的安排選項,以適應患者的喜好和常規。這種便利因素吸引了尋求適合其忙碌生活方式的治療方法的人。此外,私人診所的設立也促進了市場的良性競爭。這項競賽鼓勵治療方法、技術採用和患者服務方面的創新,最終提高整個行業的護理品質。此外,私人設施通常配備了最新的透析機、技術和熟練的醫務人員,確保高效和有效的治療。這種高標準的護理有助於在患者和轉診醫生之間建立信任,進一步推動患者轉診和市場成長。私人透析診所為尋求透析服務的患者提供替代選擇,有助於減輕公共醫療保健系統的負擔。這一點在公共資源有限的地區尤其重要,因為私立中心可以減輕醫療基礎設施的壓力。
連續門診腹膜透析 (CAPD) 和自動腹膜透析 (APD) 的需求不斷成長
連續流動腹膜透析(CAPD)和自動腹膜透析(APD)的需求不斷成長正在推動市場成長。這些先進的腹膜透析技術具有許多優勢,使其越來越受歡迎。 CAPD和APD為患者提供比傳統中心血液透析更靈活、更方便的治療選擇。 CAPD 允許患者全天手動更換透析液,從而在接受治療的同時提供更大的自由度和繼續日常活動的能力。 APD 透過利用機器在夜間自動進行透析液交換,使患者在睡眠時接受治療,進一步提高了便利性。對 CAPD 和 APD 的需求源於其穩定、持續的毒素清除能力,從而使血液化學成分更加穩定並改善整體健康狀況。這些技術也最大限度地減少了頻繁前往透析中心的需要,減少了對患者日常生活的干擾。此外,CAPD 和 APD 非常適合家庭護理,符合個人化醫療保健和遠端監控日益成長的趨勢。患者可以接受在家中執行這些手術的培訓,讓他們有一種對治療的授權和控制感。隨著患者和醫療保健提供者越來越認知到 CAPD 和 APD 的好處,對這些技術的需求預計將會上升。這反過來又透過鼓勵腹膜透析技術的進一步研究和創新以及為選擇這些方法的患者擴大培訓計劃和支援服務來推動市場成長。
The global dialysis market size reached US$ 115.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.3% during 2024-2032. The increasing availability of reimbursement policies for dialysis treatments, the rising number of kidney transplant patients requiring post-operative dialysis, and the growing focus on early diagnosis and intervention for kidney diseases are some of the factors propelling the market.
Dialysis is a crucial renal replacement therapy for individuals whose kidneys cannot function naturally. This medical procedure plays a vital role in eliminating toxins, excess water, salts, and solutes from the patient's bloodstream, effectively restoring a healthier balance. The primary objective of dialysis is to purify the blood and restore proper electrolyte levels within the body. This therapy comes in two main forms: hemodialysis and peritoneal dialysis. Hemodialysis involves the external purification of blood, a process that occurs outside the body. This technique effectively cleanses the blood of impurities, helping patients regain stability. On the other hand, peritoneal dialysis relies on the peritoneum, a lining within the abdomen, to purify the blood. By utilizing the peritoneum as a dialysis medium, this method offers an internal approach to blood cleansing. Both hemodialysis and peritoneal dialysis are instrumental in treating various kidney-related conditions. These treatments are commonly employed for addressing acute renal injuries, managing chronic kidney diseases, supporting kidney transplant procedures, or serving as a permanent solution when transplantation is not a viable option. The significance of dialysis cannot be overstated, as it significantly enhances the quality of life for individuals grappling with kidney dysfunctions. Through careful implementation and ongoing advancements in medical technology, dialysis continues to serve as a lifeline for patients needing renal support.
The global market is majorly driven by the increasing prevalence of chronic kidney diseases. In line with this, the rising aging population prone to kidney-related issues is significantly contributing to the market. Furthermore, the growing awareness about renal health and available treatment options is positively influencing the market. Apart from this, the rapid technological advancements leading to more efficient dialysis procedures are offering numerous opportunities for the market. Moreover, the heavy investments in research and development of innovative dialysis techniques are catalyzing the market. Besides, the higher incidence of diabetes, a major contributor to kidney diseases, is propelling the demand for dialysis. Additionally, the expansion of healthcare infrastructure in developing regions is providing a boost to the market. The escalating demand for home-based dialysis solutions is strengthening the market.
Increasing lifestyle changes lead to kidney complications
The escalating trend of lifestyle changes is stimulating the market. Modern lifestyles characterized by poor dietary habits, sedentary routines, and high-stress levels contribute to a rise in kidney complications. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues has subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further driving the growth of the dialysis market. Consequently, healthcare providers, medical device manufacturers, and researchers are motivated to develop innovative solutions and strategies to address this growing demand and offer effective dialysis interventions.
Expansion of private dialysis clinics and centers
The expansion of private dialysis clinics and centers is bolstering the market. These private facilities offer several key advantages that contribute to their impact on market expansion. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization enhances patient satisfaction and outcomes, attracting a larger clientele and boosting market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.
Rising demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)
The escalating demand for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) is fueling the market growth. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, drives market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.
IMARC Group provides an analysis of the key trends in each segment of the global dialysis market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, product and services, and end user.
Hemodialysis
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis
Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Hemodialysis dominates the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes hemodialysis (conventional hemodialysis, short daily hemodialysis, and nocturnal hemodialysis) and peritoneal dialysis (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)). According to the report, hemodialysis represented the largest segment.
Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses critical medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology has improved treatment outcomes and enhanced patient experiences.
Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions has widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.
Services
Equipment
Dialysis Machines
Water Treatment Systems
Others
Consumables
Dialyzers
Catheters
Others
Dialysis Drugs
Services dominates the market
The report has provided a detailed breakup and analysis of the market based on the product and services. This includes services, equipment (dialysis machines, water treatment systems, and others), consumables (dialyzers, catheters, and others), and dialysis drugs. According to the report, services represented the largest segment.
The services segment is vital in driving market growth within the dialysis industry. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues.
Furthermore, the services segment includes patient education and awareness initiatives. These programs empower patients with knowledge about kidney health, available treatment options, and self-care practices. By raising awareness and promoting early intervention, these educational efforts contribute to higher demand for dialysis services. The expansion of telehealth services is also a driving factor. Remote monitoring and consultation services enable patients to access medical guidance without frequent in-person visits, making dialysis care more convenient and efficient.
In-center Dialysis
Home Dialysis
In-center dialysis dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes in-center dialysis and home dialysis. According to the report, in-center dialysis represented the largest segment.
The in-center dialysis segment is a key driver of market growth within the dialysis industry. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges.
The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Patients appreciate the structured environment, professional support, and regular check-ins that in-center dialysis provides.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies.
Government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, boosting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.
Top companies are playing a crucial role in fostering the growth of the dialysis market through strategic initiatives and innovations. Armed with their extensive resources and expertise, these companies are driving market expansion in several ways. They invest heavily in research and development, leading to the creation of advanced dialysis technologies and treatment methods. This continuous innovation improves dialysis's efficacy, efficiency, and patient experience, enticing more individuals to opt for these treatments. Moreover, these companies collaborate with healthcare providers and institutions, ensuring widespread access to their products and services. Such partnerships facilitate the integration of cutting-edge dialysis solutions into existing healthcare ecosystems, thus expanding the market reach. Additionally, top companies often engage in awareness campaigns to educate the medical community and the general public about kidney health and available treatment options. This educational effort drives early diagnosis and intervention, increasing the demand for dialysis services. Besides, their global presence and distribution networks enable them to bring advanced dialysis solutions to regions with limited access to healthcare infrastructure. This expansion into underserved areas contributes to market growth by catering to a wider patient demographic.
The report has provided a comprehensive analysis of the competitive landscape in the dialysis market. Detailed profiles of all major companies have also been provided.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
DaVita Inc.
Fresenius Medical Care AG & Co. KGaA
JMS Co. Ltd.
Medtronic plc
Nikkiso Co. Ltd.
NIPRO Corporation
Satellite Healthcare Inc.
Toray Industries Inc.
Toray Industries Inc. developed Japan's first polymethyl methacrylate (PMMA) hollow fiber membrane-based hemodiafiltration device in November 2021, addressing the need for alternative materials and improved performance in artificial kidneys. The PMMA hemodiafiltration device offers excellent biocompatibility and uremic toxin removal, thereby contributing to better medical care for patients with renal failure.
In 2021, Becton Dickinson and Company received FDA clearance for the Pristine Long-Term Hemodialysis Catheter, which features a unique side-hole free symmetric Y-Tip design to address complications associated with traditional catheters.
Satellite Healthcare Inc. has introduced a new care model designed for individuals recently diagnosed with kidney disease requiring dialysis, named Kidney Care Connection (KCC) in 2022. KCC offers spacious patient rooms, a demonstration kitchen for learning about healthy meals, and the option to transition to home dialysis after a few weeks.